Argonaut Manufacturing Services, a contract development and manufacturing organization catering to the biopharma and life sciences sectors, has been chosen as the manufacturing partner for Akoya Biosciences Inc.’s IVD assays that are under...
Global pharmaceutical giant Lupin Limited (Lupin) and Avas Pharmaceuticals SRL (Avas), a prominent pharmaceutical firm recognized for its proficiency in marketing branded drugs, declared the introduction of Lupin’s orphan medication NaMuscla...
The U.S. Food and Drug Administration (FDA) has approved 510(k) clearance for Fresenius Kabi’s Adaptive Nomogram, a different algorithm to be included in the Aurora Xi Plasmapheresis System aimed at enhancing plasma collection efficiency...
Lantern Pharma has introduced a novel artificial intelligence (AI)-driven tool aimed at enhancing the accuracy, affordability, and speed of antibody-drug conjugates (ADCs) development for cancer. The AI company listed on Nasdaq is enhancing the...
Aurobindo Pharma revealed that the United States Food and Drug Administration (USFDA) has provided an establishment inspection report (EIR) to its subsidiary's active pharmaceutical ingredient (API) facility in Telangana, categorizing it as...
Clinigen, a worldwide expert in pharmaceutical services, has formed a strategic alliance with Tepsivo, a provider of digital Pharmacovigilance (PV) services. In the framework of the partnership, Clinigen has obtained a minority share in Tepsivo...
ColdVentures, a top medical device firm dedicated to fighting heat-related fatalities, has revealed a distribution deal with Medco Sports Medicine (Medco), the country's leading source of sports medicine supplies and equipment. This partnership...
Exelixis, Inc., an internationally focused oncology firm, revealed findings from a subgroup analysis of the phase 3 CABINET pivotal trial involving patients with extra-pancreatic neuroendocrine tumours (epNET) originating in the gastrointestinal...
The government is expected to grant an extension until December this year for the drug manufacturers to comply with the updated Schedule M. They stated that the drug regulations will be revised to allow for an extension of time. Once the last...
Innate Pharma SA reported that the initial patient has been dosed in its Phase 1 trial (NCT06781983), evaluating the safety and tolerability of IPH4502, a novel Antibody-Drug Conjugate (ADC), in individuals with advanced solid tumors expressing...
, CDSCO.jpg)
